China’s dermatological sector is being influenced by rising attention to skin health, urbanisation, changing self-care habits and the rapid expansion of digital commerce. According to Vyansa Intelligence, the China dermatologicals market was valued at USD 3.49 billion in 2025 and is projected to reach USD 3.9 billion by 2032, representing a CAGR of 1.6% from 2026 to 2032. The category covers treatments ranging from antifungals and medicated shampoos to hair-loss therapies, allergy remedies and paediatric dermatological products.
Vaginal antifungals represent the largest individual category, accounting for approximately 25% of the sector. Their position reflects continuing demand for treatments addressing common fungal conditions, while the purchasing environment around these products is changing as consumers increasingly seek convenience, discretion and clearer product information.
The category also illustrates the difference between traditional and digital purchasing behaviour. Physical pharmacies remain important for products requiring professional advice, but online channels can provide greater privacy and broader product selection. This is particularly relevant for sensitive health conditions where consumers may prefer discreet purchasing and delivery.
Growing urban populations and rising purchasing power are supporting demand for over-the-counter dermatological solutions. As consumers become more accustomed to integrating health and personal care into everyday routines, products addressing skin, scalp and hair concerns can increasingly become part of regular self-care rather than occasional treatment.
Hair-loss products are an important example of this shift. The report highlights growing interest in minoxidil-based solutions among younger consumers and women, reflecting the broader movement toward treating hair and scalp concerns as part of personal appearance and wellbeing.
Self-care does not necessarily mean consumers are moving away from professional healthcare. Instead, it can create a hybrid model in which individuals discover information online, consult healthcare professionals when required and purchase suitable products through either pharmacies or digital platforms.
Retail offline continues to account for approximately 65% of sales, reflecting the extensive pharmacy infrastructure and the importance of face-to-face guidance. For many dermatological treatments, consumers value the ability to ask pharmacists questions, compare products physically and obtain products immediately.
However, the role of physical retail is evolving. Consumers increasingly expect pharmacies to offer more than product availability, including knowledgeable advice and convenient services. Retailers that combine professional interaction with digital ordering, information and follow-up can respond more effectively to consumers who move between online and offline channels.
The continuing importance of pharmacies also reflects the healthcare nature of many dermatological products. Consumers may be comfortable purchasing routine treatments online, but conditions involving uncertainty, persistent symptoms or sensitive areas can still encourage professional consultation.
Digital platforms are becoming increasingly influential in how Chinese consumers discover dermatological products. Social commerce combines product education, consumer reviews, livestreaming, influencer content and purchasing within connected digital environments.
This model changes the traditional pathway from awareness to purchase. Instead of visiting a pharmacy first, consumers may encounter information about a condition or treatment through digital content, search for product comparisons and complete a purchase online.
The shift is especially relevant to younger consumers who are accustomed to mobile-first purchasing. However, dermatological products also require responsible communication because consumer-generated content can blur the distinction between general skincare advice, self-care information and medical guidance.
The growing use of digital healthcare services creates opportunities for more personalised product guidance. Online consultations, pharmacist support and technology-assisted recommendations can help consumers navigate product choices while reducing some of the uncertainty associated with purchasing health-related products online.
Artificial intelligence can potentially support these services by organising information and guiding consumers toward relevant questions or professional resources. Its role is more appropriately viewed as an assistance mechanism rather than a replacement for qualified medical diagnosis.
For sensitive conditions, digital consultation can also provide privacy benefits. Consumers may feel more comfortable seeking preliminary information or professional guidance through digital channels before deciding whether an in-person appointment is necessary.
Dermatological conditions extend beyond cosmetic concerns. Research published by China CDC Weekly found that skin diseases represented a significant health burden in China, with conditions such as dermatitis, viral skin diseases, acne and psoriasis contributing to disease burden across different age groups.
China’s National Health Commission has also highlighted the importance of strengthening skin-health prevention, monitoring and professional capacity. Its work includes attention to allergic diseases, skin-related complications and the development of healthcare resources capable of addressing dermatological needs.
This broader health perspective reinforces the importance of distinguishing dermatological treatment from purely cosmetic skincare. Effective consumer information, appropriate diagnosis and responsible treatment remain important as self-care and digital purchasing become more widespread.
Competition within China’s dermatological category is increasingly influenced by formulation development, digital distribution and consumer experience. Traditional treatments continue to have established demand, while newer formats and more specialised products can appeal to consumers seeking convenience or targeted solutions.
The report identifies more than 20 companies operating in the sector, with the leading five accounting for around 30% of sales. This indicates a relatively distributed competitive environment in which established pharmaceutical companies and domestic players can compete across different product categories and channels.
Product differentiation may increasingly depend on factors beyond the active ingredient itself. Ease of application, formulation format, packaging, digital education and access to professional advice can all influence how consumers evaluate dermatological products.
The relationship between online and offline retail is likely to remain central to the category. Physical pharmacies provide immediate access and professional interaction, while online platforms offer convenience, product discovery and discreet purchasing.
An omnichannel approach connects these strengths rather than treating them as competing models. Consumers may research a product online, seek professional advice through a pharmacy and then reorder through an e-commerce platform. Conversely, a pharmacy visit may introduce a consumer to digital services that support future purchases.
This interconnected purchasing journey reflects broader changes in Chinese healthcare consumption, where technology is increasingly integrated into information, consultation and access to products.
China’s dermatological sector is evolving through the intersection of healthcare needs, self-care, pharmacy services and digital commerce. Traditional retail remains important, but online discovery and social commerce are changing how consumers learn about and purchase treatments.
The growing focus on hair loss, sensitive health conditions and targeted dermatological solutions illustrates a broader movement toward more specialised self-care. At the same time, public-health initiatives and professional healthcare capacity remain important foundations for responsible treatment.
The direction of the sector will therefore depend not only on product demand but also on how effectively healthcare providers, pharmacies and digital platforms connect consumers with credible information and appropriate treatment options. As technology becomes more embedded in healthcare journeys, convenience and personalisation are likely to become increasingly important alongside professional guidance and responsible use.